top of page
New tech CES 2024 News.png
Press Release: December 18th, 2023

electronRx to Unveil Lung and Heart Digital Monitoring Smartphone Tech at CES 2024

  • Cambridge-based health tech innovator electronRx is today announcing plans to unveil patient health monitoring smartphone technology at CES 2024, Las Vegas in January.

  • The company will unveil foneDx, a scalable monitoring solution for pulmonary and cardiovascular health using sensors in a user’s mobile phone. 

  • foneDx is a scalable solution for patients, healthcare providers and commercial organisations and the world’s first combined digital monitoring solution.

Leading Cambridge-based health tech company electronRx is today announcing its plan to launch foneDx at CES 2024 in Las Vegas in January. foneDx is a scalable, democratised technology installed in modern smartphones and using the existing sensor technology, harnesses the power of digital monitoring to measure the user's critical heart and lung health can be monitored at home. The vision for the technology is to empower patients and healthcare professionals to manage chronic diseases effectively and lead to better clinical outcomes. Additionally, the data is real-time and invaluable for healthcare providers, pharmaceutical and research organisations and commercial companies.

foneDx - combined with a bespoke user interface app - has many applications across various industries alongside healthcare. electronRx is already receiving interest from the pharmaceutical industry, medical research organisations, mobile phone manufacturers, insurance companies, and automated car manufacturers. The company's appearance at CES 2024 will be the first time that technology manufacturers and worldwide business leaders will have the opportunity to experience foneDx and its capabilities firsthand.

Bipin Patel, CEO of electronRx, comments: "Our mission is to deliver a democratised and scalable smartphone technology that will use critical digital monitoring in pulmonary and cardiovascular to monitor patient health. Our technology is vigorously tested in healthcare settings in the UK, Japan and clinics worldwide which has proven the technology's efficacy. We are delighted to have the opportunity to demonstrate it at CES in January. I believe we have created something incredible that could turn millions of smartphones worldwide into efficient, effective and life-saving health monitors that will improve millions of people's lives through better condition management leading to better, life-saving clinical outcomes. This will change how we think of areas of healthcare, forever."

Follow us on LinkedIn

Charlotte Townsend: Head of Marketing

Email: ctownsend@electronrx.com

For media enquires, please contact:

New Website (1).png

To join our mission,

Get In Touch

electronRx partner with healthcare providers, payers and pharmaceutical companies across the globe, harnessing the power of digital biomarkers to manage breathing disorders effectively.

 

Want to learn more or request a demo?

bottom of page